RT Journal
A1 Wilson DM
T1 ANalysis of metformin treatment for adolescent obesity at 48 rather than 24 weeks after treatment cessation—reply
JF Archives of Pediatrics & Adolescent Medicine
JO Archives of Pediatrics & Adolescent Medicine
YR 2010
FD July 1
VO 164
IS 7
SP 678
OP 679
DO 10.1001/archpediatrics.2010.111
UL http://dx.doi.org/10.1001/archpediatrics.2010.111
AB 
The a priori primary end point of the study was change in adjusted BMI at the 52-week point. We fully expected that if there was an effect of metformin on BMI it would wane after drug treatment was stopped. We confirmed this expectation.